4299 related articles for article (PubMed ID: 22495656)
1. Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines.
Hashimoto H; Messerli SM; Sudo T; Maruta H
Drug Discov Ther; 2009 Dec; 3(6):243-6. PubMed ID: 22495656
[TBL] [Abstract][Full Text] [Related]
2. Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice.
Messerli SM; Ahn MR; Kunimasa K; Yanagihara M; Tatefuji T; Hashimoto K; Mautner V; Uto Y; Hori H; Kumazawa S; Kaji K; Ohta T; Maruta H
Phytother Res; 2009 Mar; 23(3):423-7. PubMed ID: 19003952
[TBL] [Abstract][Full Text] [Related]
3. CAPE (caffeic acid phenethyl ester)-based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice.
Demestre M; Messerli SM; Celli N; Shahhossini M; Kluwe L; Mautner V; Maruta H
Phytother Res; 2009 Feb; 23(2):226-30. PubMed ID: 18726924
[TBL] [Abstract][Full Text] [Related]
4. The direct PAK1 inhibitor, TAT-PAK18, blocks preferentially the growth of human ovarian cancer cell lines in which PAK1 is abnormally activated by autophosphorylation at Thr 423.
Hashimoto H; Sudo T; Maruta H; Nishimura R
Drug Discov Ther; 2010 Feb; 4(1):1-4. PubMed ID: 22491145
[TBL] [Abstract][Full Text] [Related]
5. Effective neurofibromatosis therapeutics blocking the oncogenic kinase PAK1.
Maruta H
Drug Discov Ther; 2011 Dec; 5(6):266-78. PubMed ID: 22466437
[TBL] [Abstract][Full Text] [Related]
6. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
7. 1,2,3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeability.
Takahashi H; Nguyen BCQ; Uto Y; Shahinozzaman M; Tawata S; Maruta H
Drug Discov Ther; 2017 May; 11(2):104-109. PubMed ID: 28442677
[TBL] [Abstract][Full Text] [Related]
8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
[TBL] [Abstract][Full Text] [Related]
10. Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture.
Nguyen BC; Taira N; Maruta H; Tawata S
Phytother Res; 2016 Jan; 30(1):120-7. PubMed ID: 26537230
[TBL] [Abstract][Full Text] [Related]
11. Effect of Okinawa Propolis on PAK1 Activity, Caenorhabditis elegans Longevity, Melanogenesis, and Growth of Cancer Cells.
Taira N; Nguyen BC; Be Tu PT; Tawata S
J Agric Food Chem; 2016 Jul; 64(27):5484-9. PubMed ID: 27337169
[TBL] [Abstract][Full Text] [Related]
12. From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Maruta H; Ahn MR
Eur J Med Chem; 2017 Dec; 142():229-243. PubMed ID: 28814374
[TBL] [Abstract][Full Text] [Related]
13. Frondoside A from sea cucumber and nymphaeols from Okinawa propolis: Natural anti-cancer agents that selectively inhibit PAK1 in vitro.
Nguyen BCQ; Yoshimura K; Kumazawa S; Tawata S; Maruta H
Drug Discov Ther; 2017 May; 11(2):110-114. PubMed ID: 28442678
[TBL] [Abstract][Full Text] [Related]
14. Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.
Rayala SK; Kumar R
Biomed Pharmacother; 2007 Aug; 61(7):408-11. PubMed ID: 17604944
[TBL] [Abstract][Full Text] [Related]
15. 1,2,3-Triazolyl ester of ketorolac (15K), a potent PAK1 blocker, inhibits both growth and metastasis of orthotopic human pancreatic cancer xenografts in mice.
Hennig R; Albawardi A; Almarzooqi S; Haneefa S; Imbaraj E; Zaaba NE; Nemmar A; Subramanya S; Maruta H; Adrian TE
Drug Discov Ther; 2019 Nov; 13(5):248-255. PubMed ID: 31656252
[TBL] [Abstract][Full Text] [Related]
16. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
Bianco C; Bianco R; Tortora G; Damiano V; Guerrieri P; Montemaggi P; Mendelsohn J; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2000 Nov; 6(11):4343-50. PubMed ID: 11106252
[TBL] [Abstract][Full Text] [Related]
18. Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.
Schraml P; Schwerdtfeger G; Burkhalter F; Raggi A; Schmidt D; Ruffalo T; King W; Wilber K; Mihatsch MJ; Moch H
Am J Pathol; 2003 Sep; 163(3):985-92. PubMed ID: 12937139
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of caffeic acid phenethyl ester on the growth of C6 glioma cells in vitro and in vivo.
Kuo HC; Kuo WH; Lee YJ; Lin WL; Chou FP; Tseng TH
Cancer Lett; 2006 Mar; 234(2):199-208. PubMed ID: 15885897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
